The adjustment in price target by Barclays, while maintaining an Overweight rating, suggests a continued positive outlook on STZ with a slight adjustment to expectations. This could be due to minor concerns or market adjustments. The impact on the stock price is likely neutral in the short term as the rating remains positive but the target is slightly reduced.